Liverpool owner FSG in talks over selling 30% stake to Bhatia consortium for £1.35bn

At a glance
Bhatia backed by father-in-law Lakshmi Mittal Minority stake deal values the club at £4.5bn Liverpool’s owner is in talks over selling a minority stake to a consortium led by the former Queens Park Rangers co‑owner Amit Bhatia and backed by his father-in-law Lakshmi Mittal, the billionaire Indian steel magnate. The
- Primary source
- Sport | The Guardian — Read original article
- Published
- Topic
- Finance
Bhatia backed by father-in-law Lakshmi Mittal Minority stake deal values the club at £4.5bn Liverpool’s owner is in talks over selling a minority stake to a consortium led by the former Queens Park Rangers co‑owner Amit Bhatia and backed by his father-in-law Lakshmi Mittal, the billionaire Indian steel magnate.
The Guardian understands a sale of 30% of the club is being discussed, with an offer of around £1.35bn on the table.
Fenway Sports Group confirmed in a statement to the Financial Times that it had begun negotiations with a group led by Bhatia over a potential minority share sale that would value Liverpool at about £4.5bn. Continue reading...
This summary comes from Sport | The Guardian. Read the full article at the original source.
References
More in Finance

Goldman traders are on pace for a record year. A close-up look at how they're doing it
In a new interview with CNBC, a Goldman exec breaks down what's driving stocks, where markets are headed, and how the bank’s equities desk fuels its growth.
Let’s elect candidates who will make the wealthy pay taxes
We can use some of those revenues to make Social Security contributions more equitable.
‘Don’t get suckered like I did’: I paid $185 to the wrong passport website. Can I get my money back?
“I will file a complaint with the Better Business Bureau.”
Rising Medicare Part D premiums could drive more people into Medicare Advantage plans
Medicare Advantage plans could be the winners of a decision by the Trump administration to put an early end to a program that kept the cost of Medicare prescription drug plans…